Regulations.gov document
09 Reference 7 - Integration of NAT results into hepatitis C supplemental serologic…
Supporting & Related Material · FDA-2018-D-3197 · posted Sep 25, 2018
Key facts
| Document ID | FDA-2018-D-3197-0010 |
|---|---|
| Title | 09 Reference 7 - Integration of NAT results into hepatitis C supplemental serologic testing algorithms implications for donor counseling and revision of existing algorithms |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-D-3197 |
| Posted | Sep 25, 2018 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: